Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease
Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease
Not yet recruiting · NCT07737249 · Registry updated 2026-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease | interstitial lung disease, lung disorder, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-07-30 | NCT07737249 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking Union Medical College Hospital | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College | Beijing | China | 6 |